Similarly, the ERK pathway is involved in several aspects of heart disease including cardiac hypertrophy and ischemia reperfusion damage to the heart [127,128], and NHE1 is involved in the aggravation of both of these forms of myocardial disease [3,107]. Here, SLC9A1 is linked to cardiac hypertrophy.